Recipharm AB

About Recipharm AB

Recipharm AB is a leading contract development and manufacturing organisation (CDMO) that provides comprehensive services to the pharmaceutical industry. Established with a vision to enhance the efficiency of drug development, Recipharm has grown to become a trusted partner for many global pharmaceutical companies.

The company operates multiple facilities across Europe, offering a wide range of services including formulation development, analytical testing, and commercial manufacturing. With a strong focus on quality and compliance, Recipharm adheres to the highest regulatory standards, ensuring that all products meet stringent safety and efficacy requirements.

Recipharm’s core activities encompass:

• Formulation Development: Tailoring drug formulations to meet specific therapeutic needs.
• Manufacturing: Providing scalable production solutions for both small and large-scale operations.
• Packaging: Offering innovative packaging solutions that enhance product stability and patient compliance.
• Quality Assurance: Implementing rigorous quality control measures throughout the manufacturing process.

With a commitment to sustainability, Recipharm actively seeks to reduce its environmental impact through efficient resource management and waste reduction initiatives. The company also invests in advanced technologies to streamline operations and improve productivity.

Recipharm’s vision is to be the partner of choice for pharmaceutical companies looking to bring their products to market efficiently and effectively. By leveraging its extensive expertise and state-of-the-art facilities, Recipharm aims to support the development of innovative therapies that improve patient outcomes worldwide.